Stratec Biomedical AG (SBS) Given a €59.00 Price Target by Berenberg Bank Analysts

Berenberg Bank set a €59.00 ($69.41) price objective on Stratec Biomedical AG (ETR:SBS) in a research report report published on Monday. The firm currently has a neutral rating on the stock.

Other analysts have also issued research reports about the stock. Kepler Capital Markets set a €70.00 ($82.35) price target on shares of Stratec Biomedical AG and gave the company a buy rating in a research note on Friday, October 27th. Warburg Research set a €62.00 ($72.94) price target on shares of Stratec Biomedical AG and gave the company a buy rating in a research note on Thursday, October 26th. Oddo Securities set a €58.00 ($68.24) price target on shares of Stratec Biomedical AG and gave the company a neutral rating in a research note on Monday, July 24th. Deutsche Bank AG set a €56.00 ($65.88) price target on shares of Stratec Biomedical AG and gave the company a neutral rating in a research note on Tuesday, October 24th. Finally, Oddo Bhf set a €58.00 ($68.24) price target on shares of Stratec Biomedical AG and gave the company a neutral rating in a research note on Monday, October 23rd. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of €60.50 ($71.18).

WARNING: This piece was posted by BBNS and is the property of of BBNS. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://baseballnewssource.com/markets/stratec-biomedical-ag-sbs-given-a-59-00-price-target-by-berenberg-bank-analysts/1743841.html.

About Stratec Biomedical AG

STRATEC Biomedical AG designs and manufactures solutions for automated processes in the fields of in vitro diagnostics and life sciences. The company operates through two segments, Instrumentation and All Other segments. It offers instrumentation products, such as automated analyzer systems, including THOLOS VMI-100, GEMINI, and GEMINI Combo for use in clinical diagnostics and biotechnology to laboratories, blood banks, and research institutes.

Analyst Recommendations for Stratec Biomedical AG (ETR:SBS)

Receive News & Ratings for Stratec Biomedical AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec Biomedical AG and related companies with our FREE daily email newsletter.

 


Latest News

Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
MLB Commissioner: New Rule for Pace-of-Play in 2018
MLB Commissioner: New Rule for Pace-of-Play in 2018
Alex Cobb Could Be Good Fit for Cubs
Alex Cobb Could Be Good Fit for Cubs
Joey Votto Is One of Baseball’s Best Hitters
Joey Votto Is One of Baseball’s Best Hitters
Hunter Pence May Become Part-Time Player
Hunter Pence May Become Part-Time Player
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts


Leave a Reply

 
© 2006-2017 BBNS.